第三剂百白破疫苗(DTP3)行政报告覆盖率与其他疫苗抗原的虚高程度比较
该研究将近期国家调查的免疫覆盖率估计值与相应行政报告覆盖率按国家和队列年份配对,覆盖DTP3及另外4种抗原,共纳入71项调查。结果显示所有抗原的行政报告覆盖率中位数均高于调查估计值(中位差值26%至30%),但DTP3与其他抗原的差值相似,按收入水平和Gavi资助资格分层后结果一致。
要点
- 所有抗原的行政报告覆盖率中位数均高于调查估计值,中位差值为26%至30%。
- DTP3行政报告覆盖率的虚高程度与其他抗原相似,并未更高。
- 按收入水平和Gavi资助资格分层后,上述结果保持一致。
核心结论
- 国家行政报告覆盖率估计值往往高于调查估计值,但DTP3行政报告覆盖率并未比其他抗原虚高更多。
研究设计与样本
- 研究汇编了近期国家调查的免疫覆盖率估计值(n=71),并按国家和队列年份与DTP3及另外4种抗原的相应行政报告覆盖率估计值配对。
主要发现
- 所有抗原的行政报告覆盖率中位数均高于调查估计覆盖率,中位差值为26%至30%。
- DTP3的行政报告覆盖率与调查估计值之间的差值与其他抗原相似。
- 按收入水平分层和按Gavi资助资格分层后,上述结果保持一致。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Third dose diphtheria tetanus pertussis (DTP3) administrative coverage is a commonly used indicator for immunization program performance, although studies have demonstrated data quality issues with administrative DTP3 coverage. It is possible that administrative coverage for DTP3 may be inflated more than for other antigens. To examine this, theory, we compiled immunization coverage estimates from recent country surveys (n=71) and paired these with corresponding administrative coverage estimates, by country and cohort year, for DTP3 and 4 other antigens. Median administrative coverage was higher than survey estimates of coverage for all antigens (median differences from 26 to 30%), however this difference was similar for DTP3 as for all other antigens. These findings were consistent when countries were stratified by income level and eligibility for Gavi funding. Our findings demonstrate that while country administrative coverage estimates tend to be higher than survey estimates, DTP3 administrative coverage is not inflated more than other antigens.
引用
- Dolan SB, MacNeil A. Comparison of inflation of third dose diphtheria tetanus pertussis (DTP3) administrative coverage to other vaccine antigens. Vaccine. 2017. PMID: 28527689. doi:10.1016/j.vaccine.2017.05.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。